Symbols / LNAI $0.18 -4.06%
LNAI Chart
About
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 4.46M |
| Enterprise Value | 6.72M | Income | -125.52M | Sales | — |
| Book/sh | -0.56 | Cash/sh | 0.02 | Dividend Yield | — |
| Payout | 0.00% | Employees | 29 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | -0.33 | P/C | — |
| EV/EBITDA | -0.54 | EV/Sales | — | Quick Ratio | 0.03 |
| Current Ratio | 0.03 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -7.56 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-05-14 | ROA | -13.32% |
| ROE | -3.66% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 24.19M |
| Shs Float | 14.71M | Short Float | 3.87% | Short Ratio | 2.62 |
| Short Interest | — | 52W High | 8.02 | 52W Low | 0.15 |
| Beta | 0.56 | Avg Volume | 757.69K | Volume | 1.24M |
| Target Price | — | Recom | None | Prev Close | $0.19 |
| Price | $0.18 | Change | -4.06% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.18
Latest analyst target
3. DCF / Fair value
$-6.21
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.18
Low
—
High
—
Mean
—
- AI combs colon cancer trial data to find patients who live longer - Stock Titan Mon, 09 Feb 2026 08
- LNAI Stock Price and Chart — NASDAQ:LNAI - TradingView Wed, 01 Oct 2025 13
- LNAI Stock Soars Pre-Market After Immune Cell Therapy Gains Licensee Interest - Stocktwits ue, 25 Nov 2025 08
- symbol__ Stock Quote Price and Forecast - CNN hu, 02 Oct 2025 14
- LNAI | Lunai Bioworks Inc. Common Insider Trading - Quiver Quantitative Sat, 21 Feb 2026 03
- LNAI Stock: Surging or Slipping? - StocksToTrade ue, 25 Nov 2025 08
- Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping - Morningstar hu, 19 Feb 2026 08
- Lunai Bioworks Stock Rockets 34% On AI/Zebrafish Platform Breakthrough - Nasdaq Wed, 05 Nov 2025 08
- AI Drug Discovery Pioneer Lunai Bioworks Emerges with New Identity and Streamlined 23.2M Share Structure - Stock Titan ue, 30 Sep 2025 07
- From Crash to Breakthrough: Why Lunai Bioworks (LNAI) Is Suddenly on Investors’ Radar - TechStock² Wed, 05 Nov 2025 08
- Lunai Bioworks stock plunges after announcing 10:1 reverse split - Investing.com Wed, 24 Sep 2025 07
- Lunai Bioworks Inc (LNAI) Stock Price, News & Analyst Forecast - eToro Wed, 01 Oct 2025 07
- Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance - Morningstar hu, 18 Dec 2025 08
- Lunai Bioworks (LNAI) gets first DCCT LOI after complete pancreatic tumor regression - Stock Titan ue, 25 Nov 2025 08
- AI firm Lunai Bioworks targets 30M with poorly treated Alcohol Use Disorder - Stock Titan Mon, 26 Jan 2026 08
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 250000 | — | — | VAN TILBURG MAURICE | Director | — | 2025-01-21 00:00:00 | D | nan |
| 1 | 250000 | — | — | WEINSTEIN DAVID HERSHEL | Chief Executive Officer | — | 2024-10-14 00:00:00 | D | nan |
| 2 | 1114 | — | Sale at price 1.30 per share. | WILLIAM ANDERSON WITTEKIND | Beneficial Owner of more than 10% of a Class of Security | — | 2024-07-29 00:00:00 | I | 1448.0 |
| 3 | 94526 | — | Sale at price 1.51 - 1.53 per share. | WILLIAM ANDERSON WITTEKIND | Beneficial Owner of more than 10% of a Class of Security | — | 2024-07-19 00:00:00 | I | 142827.0 |
| 4 | 16362 | — | Sale at price 1.46 per share. | WILLIAM ANDERSON WITTEKIND | Beneficial Owner of more than 10% of a Class of Security | — | 2024-07-17 00:00:00 | I | 23889.0 |
| 5 | 21954 | — | Sale at price 1.41 per share. | WILLIAM ANDERSON WITTEKIND | Beneficial Owner of more than 10% of a Class of Security | — | 2024-07-15 00:00:00 | I | 30955.0 |
| 6 | 21954 | — | Sale at price 1.41 per share. | WILLIAM ANDERSON WITTEKIND | Beneficial Owner of more than 10% of a Class of Security | — | 2024-07-15 00:00:00 | I | 30955.0 |
| 7 | 14896 | — | Sale at price 1.51 per share. | WILLIAM ANDERSON WITTEKIND | Beneficial Owner of more than 10% of a Class of Security | — | 2024-07-11 00:00:00 | I | 22493.0 |
| 8 | 110000 | — | Sale at price 1.51 - 1.55 per share. | WILLIAM ANDERSON WITTEKIND | Beneficial Owner of more than 10% of a Class of Security | — | 2024-07-05 00:00:00 | I | 168500.0 |
| 9 | 94553 | — | Sale at price 1.54 - 1.56 per share. | WILLIAM ANDERSON WITTEKIND | Beneficial Owner of more than 10% of a Class of Security | — | 2024-07-02 00:00:00 | I | 146812.0 |
Financials
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | -18.97M |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.21 |
| NormalizedEBITDA | -18.30M | -27.27M | -19.48M | -22.58M |
| TotalUnusualItems | -158.85M | -58.60M | -19.38M | -90.36M |
| TotalUnusualItemsExcludingGoodwill | -158.85M | -58.60M | -19.38M | -90.36M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -178.01M | -88.43M | -39.68M | -113.43M |
| ReconciledDepreciation | 129.09K | 121.86K | 113.50K | 123.59K |
| EBITDA | -177.15M | -85.87M | -38.86M | -112.94M |
| EBIT | -177.28M | -85.99M | -38.98M | -113.06M |
| NetInterestIncome | -609.34K | -2.43M | -706.96K | -250.80K |
| InterestExpense | 725.68K | 2.43M | 706.96K | 372.84K |
| InterestIncome | 116.35K | 122.04K | 13.18K | |
| NormalizedIncome | -19.16M | -29.82M | -20.30M | -42.05M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -178.01M | -88.43M | -39.68M | -113.43M |
| TotalExpenses | 18.55M | 27.39M | 19.60M | 22.83M |
| TotalOperatingIncomeAsReported | -188.97M | -81.64M | -38.56M | -116.08M |
| DilutedAverageShares | 16.51M | 9.75M | 5.63M | 5.25M |
| BasicAverageShares | 16.51M | 9.75M | 5.63M | 5.25M |
| DilutedEPS | -10.80 | -9.10 | -7.10 | -21.60 |
| BasicEPS | -10.80 | -9.10 | -7.10 | -21.60 |
| DilutedNIAvailtoComStockholders | -178.01M | -88.43M | -39.68M | -113.43M |
| NetIncomeCommonStockholders | -178.01M | -88.43M | -39.68M | -113.43M |
| NetIncome | -178.01M | -88.43M | -39.68M | -113.43M |
| NetIncomeIncludingNoncontrollingInterests | -178.01M | -88.43M | -39.68M | -113.43M |
| NetIncomeContinuousOperations | -178.01M | -88.43M | -39.68M | -113.43M |
| TaxProvision | 0.00 | 34.00 | -125.28K | |
| PretaxIncome | -178.01M | -88.43M | -39.68M | -113.43M |
| OtherIncomeExpense | -158.85M | -58.60M | -19.38M | -90.36M |
| SpecialIncomeCharges | -158.74M | -58.60M | -19.38M | -90.36M |
| OtherSpecialCharges | 1.30M | |||
| ImpairmentOfCapitalAssets | 170.42M | 54.25M | 18.96M | 93.25M |
| RestructuringAndMergernAcquisition | -11.68M | 3.05M | 419.18K | -2.90M |
| GainOnSaleOfSecurity | -112.15K | -1.02K | 9.00 | -32.63K |
| NetNonOperatingInterestIncomeExpense | -609.34K | -2.43M | -706.96K | -250.80K |
| InterestExpenseNonOperating | 725.68K | 2.43M | 706.96K | 372.84K |
| InterestIncomeNonOperating | 116.35K | 122.04K | 13.18K | |
| OperatingIncome | -18.55M | -27.39M | -19.60M | -22.83M |
| OperatingExpense | 18.55M | 27.39M | 19.60M | 22.83M |
| DepreciationAmortizationDepletionIncomeStatement | 129.09K | 121.86K | 113.50K | 123.59K |
| DepreciationAndAmortizationInIncomeStatement | 129.09K | 121.86K | 113.50K | 123.59K |
| ResearchAndDevelopment | 537.43K | 2.71M | 4.17M | 8.37M |
| SellingGeneralAndAdministration | 17.88M | 24.56M | 15.32M | 14.33M |
| GeneralAndAdministrativeExpense | 17.88M | 24.56M | 15.32M | 14.33M |
| OtherGandA | 17.88M | 24.56M | 15.32M | 14.33M |
| GrossProfit | 0.00 | 0.00 | ||
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| OrdinarySharesNumber | 17.74M | 15.50M | 6.37M | 5.30M |
| ShareIssued | 17.74M | 15.50M | 6.37M | 5.30M |
| NetDebt | 9.34M | 2.23M | 2.75M | |
| TotalDebt | 10.17M | 3.79M | 5.59M | 7.02M |
| TangibleBookValue | -27.48M | -27.38M | -7.79M | -636.42K |
| InvestedCapital | -11.91M | 134.43M | 51.13M | 78.40M |
| WorkingCapital | -28.11M | -28.31M | -8.46M | 3.11M |
| NetTangibleAssets | -27.48M | -27.38M | -7.79M | -636.42K |
| CapitalLeaseObligations | 737.59K | 1.34M | 969.01K | 1.24M |
| CommonStockEquity | -21.35M | 131.98M | 46.50M | 72.62M |
| TotalCapitalization | -21.35M | 131.98M | 46.50M | 77.20M |
| TotalEquityGrossMinorityInterest | -21.35M | 131.98M | 46.50M | 72.62M |
| StockholdersEquity | -21.35M | 131.98M | 46.50M | 72.62M |
| GainsLossesNotAffectingRetainedEarnings | 10.81M | -170.85K | -29.88K | -30.44K |
| OtherEquityAdjustments | 10.81M | -170.85K | -29.88K | -30.44K |
| RetainedEarnings | -510.46M | -332.46M | -244.03M | -204.35M |
| AdditionalPaidInCapital | 478.28M | 464.59M | 290.55M | 276.99M |
| CapitalStock | 17.74K | 15.85K | 6.37K | 5.30K |
| CommonStock | 17.74K | 15.85K | 6.37K | 5.30K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 29.58M | 31.15M | 11.80M | 12.01M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 424.55K | 842.39K | 775.59K | 5.56M |
| OtherNonCurrentLiabilities | 6.04M | |||
| LongTermDebtAndCapitalLeaseObligation | 424.55K | 842.39K | 775.59K | 5.56M |
| LongTermCapitalLeaseObligation | 424.55K | 842.39K | 775.59K | 985.70K |
| LongTermDebt | 4.58M | 5.78M | ||
| CurrentLiabilities | 29.16M | 30.31M | 11.02M | 6.45M |
| OtherCurrentLiabilities | 1.01M | 12.61M | 184.73K | 2.56M |
| CurrentDebtAndCapitalLeaseObligation | 9.75M | 2.94M | 4.82M | 1.45M |
| CurrentCapitalLeaseObligation | 313.05K | 493.55K | 193.42K | 253.64K |
| CurrentDebt | 9.44M | 2.45M | 4.62M | 1.20M |
| OtherCurrentBorrowings | 245.00K | 245.00K | 1.20M | |
| CurrentNotesPayable | 9.19M | 2.21M | 4.62M | 0.00 |
| PayablesAndAccruedExpenses | 18.40M | 14.76M | 6.02M | 2.43M |
| CurrentAccruedExpenses | 5.84M | 5.31M | 723.17K | 1.03M |
| Payables | 12.56M | 9.45M | 5.30M | 1.40M |
| AccountsPayable | 12.56M | 9.45M | 5.30M | 1.40M |
| TotalAssets | 8.23M | 163.13M | 58.30M | 84.63M |
| TotalNonCurrentAssets | 7.18M | 161.13M | 55.74M | 75.07M |
| OtherNonCurrentAssets | 19.85K | 21.74K | 68.64K | 20.98K |
| NonCurrentPrepaidAssets | 0.00 | 19.85K | 20.98K | |
| GoodwillAndOtherIntangibleAssets | 6.13M | 159.36M | 54.29M | 73.26M |
| OtherIntangibleAssets | 165.99K | 30.04K | 42.65M | 61.62M |
| Goodwill | 5.96M | 159.33M | 11.64M | 11.64M |
| NetPPE | 1.06M | 1.75M | 1.42M | 1.74M |
| AccumulatedDepreciation | -702.18K | -578.34K | -464.80K | -357.48K |
| GrossPPE | 1.76M | 2.33M | 1.89M | 2.10M |
| Leases | 224.63K | 224.63K | 224.63K | 224.63K |
| OtherProperties | 1.33M | 1.91M | 1.49M | 1.70M |
| MachineryFurnitureEquipment | 205.40K | 195.83K | 172.86K | 172.86K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 1.05M | 2.00M | 2.57M | 9.57M |
| OtherCurrentAssets | 566.08K | 668.93K | 690.92K | 393.00K |
| PrepaidAssets | 232.94K | |||
| Receivables | 0.00 | 1.11M | 0.00 | 1.64K |
| OtherReceivables | 1.11M | 1.64K | ||
| CashCashEquivalentsAndShortTermInvestments | 480.55K | 220.47K | 1.87M | 9.17M |
| OtherShortTermInvestments | 387.85K | 0.00 | ||
| CashAndCashEquivalents | 92.70K | 220.47K | 1.87M | 9.17M |
| CashFinancial | 92.70K | 220.47K | 1.87M | 9.17M |
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| FreeCashFlow | -7.87M | -11.04M | -11.80M | -15.74M |
| RepaymentOfDebt | -870.07K | -1.12M | -560.85K | -546.65K |
| IssuanceOfDebt | 6.98M | 8.05M | 0.00 | 1.22M |
| IssuanceOfCapitalStock | 2.38M | 3.00M | 4.01M | 4.68M |
| CapitalExpenditure | -70.43K | -29.77K | -5.16K | -48.89K |
| InterestPaidSupplementalData | 24.55K | 20.13K | 352.33K | 79.72K |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 34.00 |
| EndCashPosition | 92.70K | 220.47K | 1.87M | 9.17M |
| BeginningCashPosition | 220.47K | 1.87M | 9.17M | 20.66M |
| EffectOfExchangeRateChanges | -135.89K | 60.14K | -8.39K | -5.24K |
| ChangesInCash | 8.12K | -1.71M | -7.29M | -11.49M |
| FinancingCashFlow | 8.38M | 10.52M | 4.52M | 4.25M |
| CashFlowFromContinuingFinancingActivities | 8.38M | 10.52M | 4.52M | 4.25M |
| NetOtherFinancingCharges | -971.23K | -870.07K | -1.12M | -560.85K |
| ProceedsFromStockOptionExercised | 0.00 | 341.87K | 1.62M | 134.91K |
| NetCommonStockIssuance | 2.38M | 3.00M | 4.01M | 4.68M |
| CommonStockIssuance | 2.38M | 3.00M | 4.01M | 4.68M |
| NetIssuancePaymentsOfDebt | 6.98M | 8.05M | 0.00 | -560.85K |
| NetShortTermDebtIssuance | 4.28M | 0.00 | ||
| ShortTermDebtIssuance | 4.28M | 0.00 | ||
| NetLongTermDebtIssuance | 6.98M | 8.05M | 0.00 | -560.85K |
| LongTermDebtPayments | -870.07K | -1.12M | -560.85K | -546.65K |
| LongTermDebtIssuance | 6.98M | 8.05M | 0.00 | 1.22M |
| InvestingCashFlow | -500.00K | -1.26M | -29.77K | -5.16K |
| CashFlowFromContinuingInvestingActivities | -500.00K | -1.26M | -29.77K | -5.16K |
| NetInvestmentPurchaseAndSale | -500.00K | 0.00 | ||
| PurchaseOfInvestment | -500.00K | 0.00 | ||
| NetBusinessPurchaseAndSale | 0.00 | -1.19M | 0.00 | |
| SaleOfBusiness | 0.00 | 65.85K | 0.00 | |
| PurchaseOfBusiness | 0.00 | -1.26M | 0.00 | |
| NetPPEPurchaseAndSale | 0.00 | -70.43K | -29.77K | -5.16K |
| PurchaseOfPPE | 0.00 | -70.43K | -29.77K | -5.16K |
| OperatingCashFlow | -7.87M | -10.97M | -11.77M | -15.73M |
| CashFlowFromContinuingOperatingActivities | -7.87M | -10.97M | -11.77M | -15.73M |
| ChangeInWorkingCapital | 5.86M | 8.81M | 4.31M | 1.42M |
| ChangeInOtherCurrentLiabilities | -42.56K | 11.28K | -81.28K | 10.54K |
| ChangeInPayablesAndAccruedExpense | 3.61M | 8.83M | 3.32M | 941.67K |
| ChangeInAccruedExpense | 499.33K | 4.77M | -578.81K | -139.64K |
| ChangeInPayable | 3.11M | 4.06M | 3.89M | 1.08M |
| ChangeInAccountPayable | 3.11M | 4.06M | 3.89M | 1.08M |
| ChangeInPrepaidAssets | 1.14M | 1.08M | 1.07M | 461.31K |
| ChangeInReceivables | 1.15M | -1.11M | 46.00 | 1.59K |
| OtherNonCashItems | -9.70M | 8.29M | 995.80K | -2.60M |
| StockBasedCompensation | 3.31M | 4.67M | 3.54M | 5.49M |
| UnrealizedGainLossOnInvestmentSecurities | 112.15K | 0.00 | ||
| AssetImpairmentCharge | 170.42M | 54.25M | 18.96M | 93.25M |
| DepreciationAmortizationDepletion | 129.09K | 121.86K | 113.50K | 123.59K |
| DepreciationAndAmortization | 129.09K | 121.86K | 113.50K | 123.59K |
| AmortizationCashFlow | 9.90K | 8.30K | 6.17K | 14.99K |
| AmortizationOfIntangibles | 9.90K | 8.30K | 6.17K | 14.99K |
| Depreciation | 119.19K | 113.56K | 107.32K | 108.59K |
| OperatingGainsLosses | 1.30M | 18.17K | ||
| GainLossOnSaleOfPPE | 0.00 | 18.17K | 0.00 | |
| NetIncomeFromContinuingOperations | -178.01M | -88.43M | -39.68M | -113.43M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for LNAI
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|